CCR8 is a new therapeutic target in cutaneous T-cell lymphomas

Affiliations

• ¹ INSERM, U955, Henri Mondor Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris Est Créteil, Créteil, France.
• ² Department of Dermatology, AP-HP, Saint Louis Hospital, Paris, France.
• ³ Institut de Recherche Saint-Louis, Université de Paris, Paris, France.
• ⁴ INSERM, UMR 976 "Human Immunology, Pathophysiology and Immunotherapy," Paris, France.
• ⁵ Department of Dermatology, Charité Hospital, Berlin, Germany.
• ⁶ INSERM, Unité Mixte de Recherche 1160, Paris, France.
• ⁷ Department of Hematology, AP-HP, Saint Louis Hospital, Paris, France.
• ⁸ Department of Pathology, AP-HP, Saint Louis Hospital, Paris, France.
• ⁹ Department of Pathology, Henri Mondor Hospital, AP-HP, Paris, France.
• ¹⁰ Department of Tumor Genomics and Pharmacology, AP-HP, Saint Louis Hospital, Paris, France; and.
• ¹¹ Department of Dermatology, Dana Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA.